Sponsored content
Latest news
Mike Murphy on mitochondria and keeping them healthy
The Co-Creator of MitoQ, Professor Mike Murphy, dives into the science behind mitochondrial health and the relationship with aging.
Mike Murphy is Professor of Mitochondrial...
Growing the longevity startup wave through community
From connecting like-minded people to mentors illuminating the path to startup, the On Deck Longevity Biotech Fellowship is determined to foster longevity innovation.
Just a...
New chewable NMN-C tablets to boost NAD+
Elevant launches new Optima supplement to boost NAD+ levels and aims to dispel “myths” about NMN purity.
Following the introduction of its Prime supplement earlier...
MindScopic raise $550,000 for nootropic supplements
MindScopic's nootropics are designed to improve the functioning of the brain; company will use new seed round of $550,000 to commence longevity R&D.
Based in...
Wealth of experience will foster longevity biotech ideas
The On Deck Longevity Biotech Fellowship has a smörgåsbord of experience lined up, from founders to investors and we're onboard!
Last week we looked at...
Personalised longevity in an app
Span taps into wearable data and connects you with a team of experts for personalised longevity guidance and programmes for nutrition, exercise and sleep.
When...
You might also like
Peptide therapeutics company targets age-related disease
Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies.
Earlier this month, we brought you the...
Accelerating antiaging research by hacking longevity
Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field.
Kicking off...
X marks the spot for meaningful information on aging and cognition
Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline.
A new paper published in Jama...
SENS spin-out Underdog closes $10m financing round
Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital.
Michael Greve’s Kizoo Technology Capital Group led the...
Unlocking ovarian aging could prolong fertility and delay menopause
Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...
